SBIR/STTR Research Award

ORGAN CROPRESERVATION USING MOLECULAR ICE CONTROL

Award identifier e397a501794e1e674d2ebb1a94ae85de5778a7be1135e0c69be750f8a6ecf382Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$130,342

Program and phase

SBIR · Phase I

Award year

2003

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
ORGAN RECOVERY SYSTEMS, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Donated organs are used to extend life for thousands of people each year. Unfortunately, the availability of donor organs is greatly outweighed by current demand causing enormous shortages. The problem is compounded by the time critical nature of transplantation as the organ health begins to deteriorate rapidly during transport from donor to recipient. A mechanism that provided open-ended storage periods for donated organs would eliminate the detrimental effects of prolonged cold ischemia and improve organ transplant success by lifting time limits for improved tissue-typing and extended immunological preconditioning. The objective of this study is to determine if a new cryopreservation method using molecular ice control technology in a vitrification process can successfully block ice formation during preservation and permit long-term storage in a rat kidney model. We will evaluate vitrification solutions formulated with natural and synthetic molecular ice blocking compounds that are capable of limiting ice nucleation and growth. In this proposal, both in vitro and in vivo studies will be conducted to assess the viability and function of rat kidneys following vitrification with molecular ice control formulations and a standard vitrification solution. It is anticipated that solutions containing molecular ice control compounds will experience less ice formation than a standard vitrification solution and result in better renal function following transplantation.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.